公开(公告)号：US09789066B2

公开(公告)日：2017-10-17

申请号：US14592176

申请日：2015-01-08

申请人： JOHNSON & JOHNSON CONSUMER INC.

发明人： Christopher E. Szymczak ,  Vipul Dave ,  Gerard P. McNally ,  David B. Cochran ,  Gregory Koll ,  Stephen Ulrich

IPC分类号： B01J2/00 ,  B01J2/18 ,  A61K9/20 ,  A61K31/137 ,  A61K31/138 ,  A61K31/167 ,  A61K9/50

CPC分类号： A61K9/2095 ,  A61K9/2081 ,  A61K9/50 ,  A61K31/137 ,  A61K31/138 ,  A61K31/167 ,  B01J2/006 ,  B01J2/18

摘要： In one aspect the present invention features process for making a tablet comprising at least one pharmaceutically active agent, said method comprising the step of applying radiofrequency energy to a powder blend to sinter said powder blend into said tablet, wherein said powder blend comprises lossy coated particles and said at least one pharmaceutically active agent, wherein said lossy coated particles comprises a substrate that is at least partially coated with a lossy coating comprising at least one activator, wherein said substrate has a Q value of greater than 100 and said activator has a Q value of less than 75.

公开(公告)号：US20180333354A1

公开(公告)日：2018-11-22

申请号：US15879740

申请日：2018-01-25

申请人： Johnson & Johnson Consumer Inc.

发明人： Gerard P. McNally ,  Gregory Koll ,  Oliver Anderson

IPC分类号： A61K9/00 ,  A23G3/54 ,  A23G3/38

CPC分类号： A61K9/0056 ,  A23G3/38 ,  A23G3/54 ,  A23V2002/00 ,  A23V2250/5118 ,  A23V2250/6422 ,  A61K9/209

摘要： The present invention relates to a lozenge dosage form.

公开(公告)号：US20170354606A1

公开(公告)日：2017-12-14

申请号：US15689076

申请日：2017-08-29

申请人： Johnson & Johnson Consumer Inc.

发明人： Christopher E. Szymczak ,  Vipul Dave ,  Gerard P. McNally ,  David B. Cochran ,  Gregory Koll ,  Stephen Ulrich

IPC分类号： A61K9/20 ,  B01J2/00 ,  A61K9/50 ,  A61K31/137 ,  B01J2/18 ,  A61K31/138 ,  A61K31/167

CPC分类号： A61K9/2095 ,  A61K9/2081 ,  A61K9/50 ,  A61K31/137 ,  A61K31/138 ,  A61K31/167 ,  B01J2/006 ,  B01J2/18

摘要： In one aspect the present invention features process for making a tablet comprising at least one pharmaceutically active agent, said method comprising the step of applying radiofrequency energy to a powder blend to sinter said powder blend into said tablet, wherein said powder blend comprises lossy coated particles and said at least one pharmaceutically active agent, wherein said lossy coated particles comprises a substrate that is at least partially coated with a lossy coating comprising at least one activator, wherein said substrate has a Q value of greater than 100 and said activator has a Q value of less than 75.

公开(公告)号：US20180263902A1

公开(公告)日：2018-09-20

申请号：US15463609

申请日：2017-03-20

申请人： Johnson & Johnson Consumer Inc.

发明人： Gregory Koll ,  Gerard McNally ,  Christopher E. Szymczak

IPC分类号： A61K9/00 ,  A61K9/20 ,  A61K31/167

CPC分类号： A61K9/0056 ,  A61K9/2081 ,  A61K9/2095 ,  A61K9/5036 ,  A61K31/167

摘要： In one aspect the present invention features a process for making a tablet comprising the step of applying radiofrequency energy to a powder blend comprising lossy coated particles and at least one pharmaceutically active agent to sinter said powder blend into a tablet, said lossy coated particles comprising a substrate having a Q value of greater than 100 that is at least partially coated with a lossy coating comprising Hydrogenated Starch Hydrolysate.